Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Early Vascular Aging (EVA) -

Early Vascular Aging (EVA) (eBook)

New Directions in Cardiovascular Protection
eBook Download: PDF | EPUB
2015 | 1. Auflage
376 Seiten
Elsevier Science (Verlag)
978-0-12-801676-3 (ISBN)
Systemvoraussetzungen
Systemvoraussetzungen
108,00 inkl. MwSt
(CHF 105,50)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Early Vascular Aging (EVA): New Directions in Cardiovascular Protection brings together the last decade of research related to the characterization of EVA, as well as the predictive power of pulse wave velocity (PWV). The book presents a novel approach to the problem of cardiovascular disease, showing it in relation to great vessels disease and revealing a comprehensive approach to the problem of increased rigidity of the great vessels, its causes, and further consequences. Information provided is accompanied by online access to a supplemental website with video clips of anatomic specimens, cardiac imaging, and surgical procedures. - Introduces the latest information on early vascular aging (EVA), complete with summaries of recent evidence and guidelines for relevant risk factor control - Ideal reference for the study of vascular aging, pulse wave velocity, arteriosclerosis, EVA, arterial stiffness, vascular, PWV biomarkers, and cardiovascular disease - Contains all the relevant information available from different fields of knowledge (from basic biology to epidemiology) in regard to EVA - Provides evidence that leads to a new target for interventions, early vascular aging (EVA) in subjects with early onset increased arterial stiffness - Includes online access to a supplemental website with video clips of anatomic specimens, cardiac imaging, and surgical procedures
Early Vascular Aging (EVA): New Directions in Cardiovascular Protection brings together the last decade of research related to the characterization of EVA, as well as the predictive power of pulse wave velocity (PWV). The book presents a novel approach to the problem of cardiovascular disease, showing it in relation to great vessels disease and revealing a comprehensive approach to the problem of increased rigidity of the great vessels, its causes, and further consequences. Information provided is accompanied by online access to a supplemental website with video clips of anatomic specimens, cardiac imaging, and surgical procedures. - Introduces the latest information on early vascular aging (EVA), complete with summaries of recent evidence and guidelines for relevant risk factor control- Ideal reference for the study of vascular aging, pulse wave velocity, arteriosclerosis, EVA, arterial stiffness, vascular, PWV biomarkers, and cardiovascular disease- Contains all the relevant information available from different fields of knowledge (from basic biology to epidemiology) in regard to EVA- Provides evidence that leads to a new target for interventions, early vascular aging (EVA) in subjects with early onset increased arterial stiffness- Includes online access to a supplemental website with video clips of anatomic specimens, cardiac imaging, and surgical procedures

List of Contributors


Enrico Agabiti-Rosei,     Clinica Medica, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

Tine de Backer

Heymans Institute of Pharmacology, Ghent University, Ghent, Belgium

Cardiovascular Center, University Hospital Ghent, Ghent, Belgium

Luc van Bortel,     Heymans Institute of Pharmacology, Ghent University, Ghent, Belgium

Pierre Boutouyrie

Department of Pharmacology, Hôpital Européen Georges Pompidou – Assistance Publique Hôpitaux de Paris, Paris, France

Institut National de la Santé et de la Recherche Médicale—INSERM U970, Paris, France

Université Paris-Descartes, Paris, France

Michel Burnier,     Service of Nephrology and Hypertension, University Hospital, Lausanne, Switzerland

Mark Caulfield,     William Harvey Research Institute, NIHR Biomedical Research Unit in Cardiovascular Disease at Barts Queen Mary University of London, UK

Pascal Challande,     Université Pierre et Marie Curie, CNRS—UMR 7190, Paris, France

Pedro G. Cunha

Center for the Research and Treatment of Arterial Hypertension and Cardiovascular Risk, Internal Medicine Department, Guimarães—Centro Hospitalar do Alto Ave/Minho University, Guimarães, Portugal

Life and Health Science Research Institute (ICVS), School of Health Science, University of Minho, Braga, Portugal

ICVS/3B’s—PT Government Associate Laboratory, Braga/Guimarães, Portugal

Stephanie Debette

Department of Neurology, University Hospital of Bordeaux, and Center for Epidemiology and Public Health—INSERM U897, University of Bordeaux, France

Department of Neurology, Boston University School of Medicine, Boston, MA, USA

Andreas Edsfeldt

Experimental Cardiovascular Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden

Department of Cardiology, University Hospital of Skåne, Malmö/Lund, Sweden

Isabel Ferreira

Department of Clinical Epidemiology and Medical Technology Assessment, and CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, The Netherlands

School of Public Health, University of Queensland, Brisbane, Australia

Stanley S. Franklin,     Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine, CA, USA

Frej Fyhrquist,     Minerva Institute, Helsinki, Finland

Panagiotis I. Georgianos,     Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

Isabel Gonçalves

Experimental Cardiovascular Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden

Department of Cardiology, University Hospital of Skåne, Malmö/Lund, Sweden

Dagmara Hering,     Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland

Jens Jordan,     Institute of Clinical Pharmacology, Medical School Hannover, Hannover, Germany

Vasilios Kotsis,     Hypertension Centre of Excellence, 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University Thessaloniki, Thessaloniki, Greece

Michaela Kozakova,     Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

Roel J. van de Laar,     Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands

Patrick Lacolley

Institut National de la Santé et de la Recherche Médicale—INSERM U116

Université de Lorraine, Nancy, France

Jérémy Lagrange

Institut National de la Santé et de la Recherche Médicale—INSERM U116

Université de Lorraine, Nancy, France

Edward G. Lakatta,     Laboratory of Cardiovascular Science, Intramural Research Program, Biomedical Research Center, National Institute on Aging, NIH, Baltimore, MD, USA

Irene Lambrinoudaki,     Medical School, University of Athens, Athens, Greece

Stéphane Laurent

Department of Pharmacology, Hôpital Européen Georges Pompidou – Assistance Publique Hôpitaux de Paris, Paris, France

Université Paris-Descartes, Paris, France

Institut National de la Santé et de la Recherche Médicale—INSERM U970, Paris, France

Yimin Lu,     Service of Nephrology and Hypertension, University Hospital, Lausanne, Switzerland

Carmel M. McEniery,     Department Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK

Krzysztof Narkiewicz,     Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland

Jan Nilsson,     Experimental Cardiovascular Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden

Peter M. Nilsson,     Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden

Juan E. Ochoa,     Department of Cardiovascular Neural and Metabolic Sciences, S. Luca Hospital, IRCCS Istituto Auxologico Italiano, Milan, Italy

Michael H. Olsen

Cardiovascular and Metabolic Preventive Clinic, Department of Endocrinology, Center for Individualized Medicine in Arterial Diseases, Odense University Hospital, Odense, Denmark

Hypertension in Africa Research Team, School for Physiology, Nutrition and Consumer Sciences, North-West University,Potchefstroom, South Africa

Carl J. Östgren,     Department of Medical and Health Sciences, Linköping University, Linköping, Sweden

Carlo Palombo,     Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy

Gianfranco Parati

Department of Health Sciences, University of Milano-Bicocca, Milan, Italy

Department of Cardiovascular Neural and Metabolic Sciences, S. Luca Hospital, IRCCS Istituto Auxologico Italiano, Milan, Italy

Veronique Regnault

Institut National de la Santé et de la Recherche Médicale—INSERM U116

Université de Lorraine, Nancy, France

Meixia Ren,     William Harvey Research Institute, Centre for Clinical Pharmacology, Queen Mary University of London, UK

Ernst Rietzschel

Departments of Cardiovascular Diseases & Public Health, Ghent University, Ghent, Belgium

Department of Cardiology, Ghent University Hospital, Ghent, Belgium

Damiano Rizzoni,     Clinica Medica, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

Paolo Salvi,     Department of Cardiovascular Neural and Metabolic Sciences, S. Luca Hospital, IRCCS Istituto Auxologico Italiano, Milan, Italy

Pantelis A. Sarafidis,     Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

Giuseppe Schillaci

Department of Medicine, University of Perugia, Perugia, Italy

Unit of Internal Medicine, Terni University Hospital, Terni, Italy

Arno Schmidt-Truksäss,     Department of Sport, Exercise and Health, Sport and Exercise Medicine, University of Basel, Basel, Switzerland

Angelo Scuteri,     Hospital San Raffaele Pisana, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy

Patrick Segers,     IBiTech-bioMMeda, iMinds Medical IT, Ghent University, Gent, Belgium

Thomas Sehestedt,     Department of Cardiology, Herlev...

Erscheint lt. Verlag 6.8.2015
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Geriatrie
Medizinische Fachgebiete Innere Medizin Kardiologie / Angiologie
Studium 1. Studienabschnitt (Vorklinik) Physiologie
ISBN-10 0-12-801676-0 / 0128016760
ISBN-13 978-0-12-801676-3 / 9780128016763
Haben Sie eine Frage zum Produkt?
PDFPDF (Adobe DRM)
Größe: 16,9 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

EPUBEPUB (Adobe DRM)
Größe: 11,2 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
'Ars echocardiographica' - Schritt für Schritt zur …

von Andreas Hagendorff; Stephan Stoebe

eBook Download (2021)
Urban & Fischer Verlag - Fachbücher
CHF 126,95